You're reading the free version. Trader adds the live tape and alerts.
Start tracking
EXOZ Exercise Disclosure
Perriman Damien Alan · SEC Form 4 · Filed Aug 25, 2026
Exercise
Reported value range
Not reported
Perriman Damien Alan Chief Commercial Officer
EXOZ
Exozymes Inc.
EXOZ
Transaction date
Aug 19, 2026
Public filing date
Aug 25, 2026
Filing lag
Filed 6 days later
EXOZ daily price context
No linked price history
This asset is not matched to a market-data symbol.
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 19,612 shares
- SEC ownership
- Direct
- Transaction code
- M
- Form
- 4
- Filing identifier
- 0001493152-26-040129
Filing cohort
Transactions in this filing
Showing 2 of 2
Trades
2
Issuers
1
Estimated value
$0
Buys / sales
0 / 0
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Exozymes Inc. EXOZ Current | Exercise | Aug 19, 2026 | Not reported |
| Exozymes Inc. EXOZ | Exercise | Aug 19, 2026 | $0 |